Petra A. Priemel

793 total citations
16 papers, 606 citations indexed

About

Petra A. Priemel is a scholar working on Pharmaceutical Science, Materials Chemistry and Spectroscopy. According to data from OpenAlex, Petra A. Priemel has authored 16 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 7 papers in Materials Chemistry and 4 papers in Spectroscopy. Recurrent topics in Petra A. Priemel's work include Drug Solubulity and Delivery Systems (10 papers), Crystallization and Solubility Studies (6 papers) and Advanced Drug Delivery Systems (5 papers). Petra A. Priemel is often cited by papers focused on Drug Solubulity and Delivery Systems (10 papers), Crystallization and Solubility Studies (6 papers) and Advanced Drug Delivery Systems (5 papers). Petra A. Priemel collaborates with scholars based in Denmark, Finland and New Zealand. Petra A. Priemel's co-authors include Thomas Rades, Holger Grohganz, Korbinian Löbmann, Riikka Laitinen, Clare J. Strachan, Anette Müllertz, Line Hagner Nielsen, Guy Van den Mooter, René Holm and Heidi Lopez de Diego and has published in prestigious journals such as Advanced Drug Delivery Reviews, International Journal of Molecular Sciences and International Journal of Pharmaceutics.

In The Last Decade

Petra A. Priemel

16 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra A. Priemel Denmark 13 430 256 110 97 84 16 606
Sophie‐Dorothée Clas Canada 12 386 0.9× 203 0.8× 107 1.0× 120 1.2× 71 0.8× 16 691
Ilse Weuts Belgium 11 509 1.2× 312 1.2× 99 0.9× 147 1.5× 68 0.8× 12 671
Waree Limwikrant Japan 16 254 0.6× 213 0.8× 131 1.2× 110 1.1× 101 1.2× 41 651
Helvécio Vinícius Antunes Rocha Brazil 13 244 0.6× 243 0.9× 117 1.1× 75 0.8× 72 0.9× 59 579
M. Serpil Kislalioglu United States 11 456 1.1× 231 0.9× 74 0.7× 121 1.2× 51 0.6× 14 633
Bert van Veen Finland 11 461 1.1× 222 0.9× 136 1.2× 51 0.5× 52 0.6× 24 741
Naila A. Mugheirbi Ireland 13 303 0.7× 215 0.8× 84 0.8× 67 0.7× 75 0.9× 18 479
Moji Christianah Adeyeye United States 15 405 0.9× 106 0.4× 82 0.7× 81 0.8× 55 0.7× 33 645
Catarina Marques Fernandes Portugal 7 359 0.8× 147 0.6× 98 0.9× 126 1.3× 61 0.7× 10 517
S. Anguiano-Igea Spain 15 394 0.9× 130 0.5× 85 0.8× 115 1.2× 50 0.6× 27 663

Countries citing papers authored by Petra A. Priemel

Since Specialization
Citations

This map shows the geographic impact of Petra A. Priemel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra A. Priemel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra A. Priemel more than expected).

Fields of papers citing papers by Petra A. Priemel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra A. Priemel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra A. Priemel. The network helps show where Petra A. Priemel may publish in the future.

Co-authorship network of co-authors of Petra A. Priemel

This figure shows the co-authorship network connecting the top 25 collaborators of Petra A. Priemel. A scholar is included among the top collaborators of Petra A. Priemel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra A. Priemel. Petra A. Priemel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Priemel, Petra A., et al.. (2018). Poly(ethylene carbonate)-containing polylactic acid microparticles with rifampicin improve drug delivery to macrophages. Journal of Pharmacy and Pharmacology. 70(8). 1009–1021. 10 indexed citations
2.
Löbmann, Korbinian, Petra A. Priemel, Holger Grohganz, et al.. (2017). Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin. European Journal of Pharmaceutics and Biopharmaceutics. 122. 62–69. 34 indexed citations
3.
Priemel, Petra A., Holger Grohganz, René Holm, et al.. (2017). Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ. International Journal of Pharmaceutics. 519(1-2). 343–351. 40 indexed citations
4.
Priemel, Petra A., Y. Karrout, Virginie Driss, et al.. (2017). Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis. International Journal of Pharmaceutics. 533(1). 26–33. 9 indexed citations
5.
Laitinen, Riikka, Korbinian Löbmann, Holger Grohganz, et al.. (2017). Supersaturating drug delivery systems: The potential of co-amorphous drug formulations. International Journal of Pharmaceutics. 532(1). 1–12. 105 indexed citations
6.
Müllertz, Anette, et al.. (2017). Amorphous is not always better—A dissolution study on solid state forms of carbamazepine. International Journal of Pharmaceutics. 522(1-2). 74–79. 18 indexed citations
7.
Kłodzińska, Sylvia N., Petra A. Priemel, Thomas Rades, & Hanne Mørck Nielsen. (2017). Combining diagnostic methods for antimicrobial susceptibility testing – A comparative approach. Journal of Microbiological Methods. 144. 177–185. 12 indexed citations
8.
Kłodzińska, Sylvia N., Petra A. Priemel, Thomas Rades, & Hanne Mørck Nielsen. (2016). Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches. International Journal of Molecular Sciences. 17(10). 1688–1688. 22 indexed citations
9.
Löbmann, Korbinian, Holger Grohganz, René Holm, et al.. (2016). Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit® E PO. Journal of Drug Delivery Science and Technology. 34. 32–40. 33 indexed citations
10.
Priemel, Petra A., Holger Grohganz, & Thomas Rades. (2015). Unintended and in situ amorphisation of pharmaceuticals. Advanced Drug Delivery Reviews. 100. 126–132. 30 indexed citations
11.
Grohganz, Holger, Petra A. Priemel, Korbinian Löbmann, et al.. (2014). Refining stability and dissolution rate of amorphous drug formulations. Expert Opinion on Drug Delivery. 11(6). 977–989. 121 indexed citations
12.
Grohganz, Holger, Korbinian Löbmann, Petra A. Priemel, et al.. (2013). Amorphous drugs and dosage forms. Journal of Drug Delivery Science and Technology. 23(4). 403–408. 60 indexed citations
13.
Priemel, Petra A., Riikka Laitinen, Holger Grohganz, Thomas Rades, & Clare J. Strachan. (2013). In situ amorphisation of indomethacin with Eudragit® E during dissolution. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 1259–1265. 43 indexed citations
14.
Priemel, Petra A., Riikka Laitinen, Holger Grohganz, et al.. (2013). Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug–polymer mixtures. International Journal of Pharmaceutics. 456(2). 301–306. 26 indexed citations
16.
Priemel, Petra A., Holger Grohganz, Keith C. Gordon, Thomas Rades, & Clare J. Strachan. (2012). The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin. European Journal of Pharmaceutics and Biopharmaceutics. 82(1). 187–193. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026